Migraines with visual disturbance

This piece is for general information and discussion only. It is not medical or legal advice.

1. Context

Migraine with visual disturbance affects a significant proportion of women and frequently appears during reproductive years. Epidemiological studies show women experience migraine around three times more often than men. Visual symptoms can be dramatic, difficult to describe and sometimes overlap with conditions such as transient ischaemic attack, retinal disease, raised intracranial pressure or hypertensive disorders. Misinterpretation carries system‑level consequences: over‑investigation contributes to referral pressures, while under‑recognition risks delayed escalation for time‑critical conditions.

Across the NHS, migraine with visual disturbance sits at the junction of neurology, ophthalmology, general practice, stroke pathways and community optometry. Investigations into women’s health repeatedly note that atypical sensory or neurological symptoms are sometimes minimised or attributed to anxiety. This shapes how women’s visual symptoms are interpreted, documented and escalated.

2. Evidence and policy

Guidance from NICE and the Royal College of Physicians highlights that clinicians typically assess the onset, evolution and laterality of visual disturbance, the presence of headache, associated neurological symptoms and vascular risk. National stroke pathways emphasise the distinction between visual aura and posterior circulation events. Ophthalmology guidance notes that most migraine aura is accompanied by a normal eye examination, which can help exclude structural eye disease.

Research on women’s health shows that hormonal fluctuation, anaemia, hypertension, perimenopause and medication use may all influence symptom patterns. National inquiries into neurological presentations, although not migraine‑specific, describe repeated themes of women reporting difficulty having visual or sensory symptoms taken seriously or fully documented.

3. Interplay between optometry, primary care and specialist referral

Visual disturbance often prompts women to consult community optometrists. Urgent eye care schemes have demonstrated that optometrists commonly identify red‑flag features such as retinal pathology, field defects or raised intraocular pressure. However, migraine aura usually presents with a normal eye examination. When no ocular cause is found, referral pathways depend heavily on local arrangements, and women may be redirected to general practice without a clear escalation route.

General practice acts as the central coordinating point. Time‑limited appointments and the transient nature of aura mean that symptoms often resolve before assessment. National reviews note that fluctuating or complex visual descriptions can be interpreted as non‑urgent, and the association with hormonal change may not be explored. Guidance expects GPs to consider blood pressure, medication, red‑flag neurological features and pregnancy status where relevant.

Ophthalmology services become involved where structural pathology needs to be excluded. Many women attend eye clinics despite migraine aura typically showing normal ophthalmic findings. Investigations into care transitions describe that some women experience repeated ophthalmology assessments before neurological evaluation is considered. Conversely, some retinal causes of transient visual loss can be subtle, raising the risk of misclassification as migraine aura.

Neurology services are frequently the endpoint when symptoms remain unexplained or when they overlap with stroke, seizure or raised intracranial pressure pathways. National data show increasing demand for neurology combined with constrained specialist capacity, contributing to waiting times that may leave women without timely clarification of their symptoms.

How often is it confused?

National stroke audits report that migraine aura is one of the most common stroke mimics, although proportions vary by service. A minority of headache presentations have an ocular cause, yet some vascular causes of transient monocular visual loss are initially attributed to migraine. Evidence specific to women is limited, but wider women’s health reviews highlight that neurological symptoms in women are more likely to be reframed as stress or non‑urgent, increasing the risk of both over and under‑escalation.

4. Pregnancy and postnatal considerations

Guidance for antenatal and postnatal care highlights that new headaches with visual disturbance require careful assessment because symptoms overlap with pre‑eclampsia, blood pressure instability, dehydration and rarer neurological conditions. National maternity investigations show that women presenting repeatedly with headache and visual symptoms have occasionally been reassured without full assessment, while others with longstanding migraine aura have been escalated unnecessarily. Clear documentation and continuity of notes are repeatedly identified as safety safeguards.

System watchpoints (information only)

This section highlights system patterns seen in research, guidance and investigations. It is not medical or legal advice, and it is not a checklist for your own care.

Who the evidence represents

Much migraine research originates from predominantly white, higher‑income study populations. Evidence for diverse communities, autistic women and those with multimorbidity remains limited.

Digital design

Electronic templates vary widely. Some include fields for headache severity and photophobia but lack structured prompts for visual aura description, increasing the risk that atypical features are lost in free‑text.

Fragmented pathways

Optometry, general practice, ophthalmology and neurology operate with different referral criteria. Women report cycling between services without clear ownership of symptoms.

Transient symptoms

Aura often resolves before assessment. Once the examination normalises, documentation from the initial episode becomes critical to avoid misinterpretation.

Communication and bias

Investigations describe women reporting that complex sensory symptoms were minimised or reframed as anxiety. This pattern appears across neurological, cardiac and maternity presentations.

Workload and time pressure

High‑demand environments prioritise ruling out immediately life‑threatening conditions. Nuanced symptom exploration may be deprioritised once stroke or retinal detachment is felt to be unlikely.

What is improving

• Updated NICE guidance provides more clarity on when migraine aura should prompt further assessment.
• National decision‑support tools are strengthening recognition of neurological red flags.
• Women’s health strategies emphasise improving recognition of sensory and neurological symptoms.
• Shared care records are beginning to reduce information loss across optometry, GP, emergency and specialist services.

Where further improvement might come from

• More consistent pathways linking optometry, general practice, ophthalmology and neurology.
• Structured digital fields for visual disturbance features, including onset and evolution.
• Research on diverse presentations in women, including pregnant and perimenopausal populations.
• Interdisciplinary guidance on differentiating aura from stroke mimics.
• Public‑facing materials to help people describe visual symptoms clearly.

Readers are invited to contribute further evidence or system‑level insights by email, without sharing personal data.

Reflective questions (off‑blog)

For clinicians

Are visual symptoms captured in a structured and consistent way in local records?
Do local pathways clearly describe escalation from optometry to medical review?
How reliably are pregnancy‑related visual symptoms assessed and recorded?
Do services recognise symptom patterns linked with hormonal change?
Where do referral delays most commonly occur in the local system?

For patients and the public

How easy is it to explain visual symptoms during short appointments?
Have you had to repeat the same story across multiple services?
Did the explanation you received feel coherent and consistent across settings?
What information or tools would help you describe visual changes more confidently?
How joined‑up did your interactions with optometry, GP and specialist services feel?

Mandatory disclaimer

This article is for general information and discussion only. It is not medical or legal advice, nor a substitute for professional advice. To contribute evidence, ideas, or corrections, please email womenshealthproject@outlook.com. Please do not share personal data when emailing. Individual cases cannot be reviewed. This project does not offer any form of legal service and cannot assist with complaints, claims or individual advocacy.

This platform is independent and not affiliated with any law firm, regulator, inquiry or clinical body.

References

NICE. Headaches in over 12s: diagnosis and management. Available at: https://www.nice.org.uk. Accessed 08 Mar 2026.
Royal College of Physicians. Neurology clinical guidance. Available at: https://www.rcp.ac.uk. Accessed 08 Mar 2026.
NHS England. Stroke clinical pathways and safety guidance. Available at: https://www.england.nhs.uk. Accessed 08 Mar 2026.
HSSIB. National investigations on neurological symptom assessment. Available at: https://www.hssib.org.uk. Accessed 08 Mar 2026.
MBRRACE‑UK. Maternal morbidity and mortality reports. Available at: https://www.npeu.ox.ac.uk/mbrrace-uk. Accessed 08 Mar 2026.
ONS. Migraine prevalence statistics. Available at: https://www.ons.gov.uk. Accessed 08 Mar 2026.